Riskpilot← Back to searchSign inGet full accessInnovDr AB
ABDissolvedOrg 5590593256Medical specialists activities · NACE 8622Est. 20160 employees
Revenue 2024
SEK 181,5M
+54% vs 2023
EBITDA margin
12.9%
+25% vs 2023
Equity ratio
72.4%
Financial strength
Net profit 2024
SEK 0
0 employees
| Revenue | SEK 181,5M | +54% |
| EBITDA | SEK 23,4M | +25% |
| Net profit | SEK 0 | — |
| Total assets | SEK 293,6M | +612% |
| Equity | SEK 212,6M | +854% |
| Employees | 0 | — |
Legal name
InnovDr AB
Org number
5590593256
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 april 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva allmänmedicinsk hälso- och sjukvård, utföra resevaccinationer, företagshälsovård, försäkringsmedicinska utredningar, rehabiliteringsutredningar och därmed förenlig verksamhet,
Address
Email
ekonomi@doktor.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 4 104 | 3 877 | 13 852 | 33 981 | 54 178 | 117 875 | 181 472 |
| Staff expenses | — | — | — | — | — | — | — | −5 216 | −11 332 |
| EBITDA | −26 | 333 | 437 | 744 | 3 048 | 9 069 | 25 763 | 18 717 | 23 413 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −6 | −137 | −369 | −673 |
| EBIT | −26 | 333 | 437 | 744 | 3 048 | 9 063 | 25 626 | 18 348 | 22 740 |
| Net financials | — | −1 | −2 | −4 | −6 | −1 | 18 | 782 | 606 |
| Profit before tax | −26 | 332 | 436 | 552 | 2 283 | 6 862 | 19 216 | 0 | 0 |
| Tax | −0 | −68 | −101 | −119 | −493 | −1 426 | −3 974 | — | — |
| Net profit | −26 | 264 | 335 | 433 | 1 790 | 5 436 | 15 242 | 0 | 0 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 217 | 617 | 1 007 | 1 393 | 8 760 | 15 068 | 39 035 | 41 216 | 293 635 |
| Equity | 124 | 388 | 386 | 819 | 2 609 | 7 045 | 22 287 | 22 287 | 212 601 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Short-term debt | 93 | 229 | 621 | 386 | 5 204 | 4 876 | 7 172 | 18 929 | 81 034 |
| Total debt | 93 | 229 | 621 | 386 | 5 204 | 4 876 | 7 172 | 18 929 | 81 034 |
EBITDA margin
12.9%
This company
15.8%
Market median
-18% vs market
20162024
Equity ratio
72.4%
This company
38.2%
Market median
+90% vs market
20162024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20162024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20162024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20162024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-04-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JC Chief Auditor | Chief Auditor | 2022 | — | — |
LV | Audit | 2022 | — | — |
ST Audit | Audit | 2020 | — | — |
MA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Doktorse Nordic AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Doktorse Nordic AB
InnovDr AB Board members of InnovDr AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Christian Andersson | Chief Auditor | 0 companies |
| Lennart Victor Lindelöf | Audit | 0 companies |
| Sven Tiberiu Cristea | Audit | 0 companies |
| Matilda Anna Maria Lundblad | Chief Executive Officer | 0 companies |
| Bo Martin Lindman | Board of Directors | 0 companies |
| Anna Maria Gners Nivinger | Deputy Board Member | 0 companies |
| Martin Gösta Sellman | Deputy Board Member | 0 companies |
| Frida Marie Lundblad | Chairman | 0 companies |
| Viktor Karl Georg Sellman | Board of Directors | 0 companies |